<DOC>
	<DOCNO>NCT01371669</DOCNO>
	<brief_summary>In investigator study , regard result small cohort literature , investigator hypothesize hypoxemia frequent IPAH CPEPH . The investigator explore patient one night polysomnography transcutaneous capnography , search hypoxemia hypercapnia determine physiopathologic mechanism .</brief_summary>
	<brief_title>Screening Sleep Hypoxemia Pulmonary Arterial Hypertension</brief_title>
	<detailed_description>Pulmonary hypertension ( PH ) rare severe disease young adult , characterize progressive increase pulmonary vascular resistance lead cardiac failure death . Patients PH categorize two major group : primary PH ( PPH ) wich idiopathic , secondary PH associate many condition chronic pulmonary embolic disease ( CPED ) .Increase vascular resistance PH secondary vasoconstriction proliferative remodel process arterial wall lead obliteration small arteriole . On hand , hypoxemia know cause similar change vascular architecture . Also , small cohort study literature mention increase sleep hypoxemia prevalence accounting almost 70 % case . The mechanisms hypoxemia completely unknown.Our study observational , prospective transversal , search hypoxemic respiratory sleep disorder ( HRSD ) PPH CPEPH . Included patient one night polysomnography ( CIDELEC ) continuous measurement transcutaneous PCO2.The major objective determine prevalence HRSD , physiopathologic mechanism possible causal factor accord PH history , clinical finding hemodynamic severity .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<criteria>Patient age 18 75 year Patient IPAH ot CPEPH stable least 3 month . Stability define New York Heart Association class dyspnea six minute walk test ( 6MWT ) . Furthermore , change medical therapy occur last three month . Patients sign informed consent Patients secondary PH associate pathology outside CPEPH ( sclerodermia , systemic lupus erythematous , portal hypertension , chronic HIV infection ... ) Patients functional and/or hemodynamic degradation last 3 month change pulmonary hypertension treatment Patients obstructive restrictive ventilatory disorder Ventricular Ejection Fraction &lt; 60 % predicted Women without effective contraception Patients Body Mass Index 35 kg/m2 Patient affiliate social security scheme</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Pulmonary arterial hypertension</keyword>
	<keyword>Chronic post embolic disease</keyword>
	<keyword>Sleep hypoxemia</keyword>
	<keyword>polysomnography</keyword>
	<keyword>sleep apnea</keyword>
	<keyword>periodic respiration</keyword>
</DOC>